The highly selective VSV killing of lung cancer cells with an impaired IFN pathway due to epigenetically downregulation of IRFs indicates that these genes are ideal biomarkers for determining the susceptibility of tumors to oncolytic viral therapy. This evidence concerns the gene IFNA1 and lung carcinoma.